Related Experiment Video
Updated: Aug 8, 2026
08:24
Introduction to the Ultrasound Targeted Microbubble Destruction Technique
Published on: June 12, 2011
Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology
Shuyuan Chen1, Jia-huan Ding, Raffi Bekeredjian
1Department of Internal Medicine, Cardiology Section, Baylor University Medical Center, Baylor Heart and Vascular Institute, 621 North Hall Street, Suite H030, Dallas, TX 75226, USA.
Summary
Ultrasound targeted microbubble destruction (UTMD) offers a novel gene delivery method to pancreatic islets. This technique effectively modulated beta cell function in adult rats, showing potential for diabetes research.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Endocrinology
Background:
- Gene therapy holds promise for treating metabolic disorders.
- Efficient and targeted gene delivery to pancreatic islets remains a challenge.
- Ultrasound Targeted Microbubble Destruction (UTMD) is an emerging technology for localized therapeutic delivery.
Purpose of the Study:
- To establish and evaluate UTMD for gene delivery to pancreatic islets in adult rats.
- To assess the efficiency and specificity of gene expression in islet beta cells.
- To demonstrate the biological efficacy of UTMD-mediated gene transfer for modulating beta cell function.
Main Methods:
- Plasmids encoding reporter genes or therapeutic proteins were encapsulated into microbubbles.
- Microbubbles were systemically administered to adult rats and localized to the pancreatic microcirculation.
- Ultrasound was applied to induce targeted microbubble destruction, facilitating gene transfer into islet cells.
- Reporter gene expression (luciferase) was assessed for glucose-dependent regulation.
- Therapeutic gene delivery (human insulin, hexokinase I) efficacy was evaluated by measuring C-peptide, insulin, hexokinase I protein, and blood glucose levels.
Main Results:
- UTMD enabled specific gene delivery to pancreatic islets, confirmed by glucose-regulated reporter gene expression.
- Delivery of RIP-human insulin via UTMD increased circulating C-peptide and decreased blood glucose.
- Delivery of RIP-hexokinase I via UTMD increased islet hexokinase I protein, blood insulin, and decreased blood glucose.
- The gene delivery method demonstrated significant biological efficacy in modulating beta cell function.
Conclusions:
- UTMD provides a relatively noninvasive and effective method for gene delivery to pancreatic islets in adult animals.
- This technique achieves sufficient efficiency to modulate islet beta cell function.
- UTMD represents a promising platform for developing gene therapies for diabetes and other islet-related diseases.
